These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27839741)

  • 1. Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis.
    Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
    Semin Arthritis Rheum; 2017 Apr; 46(5):650-656. PubMed ID: 27839741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.
    Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
    Semin Arthritis Rheum; 2017 Jun; 46(6):819-827. PubMed ID: 28040244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities.
    Petri H; Nevitt A; Sarsour K; Napalkov P; Collinson N
    Arthritis Care Res (Hoboken); 2015 Mar; 67(3):390-5. PubMed ID: 25132663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study.
    Paskins Z; Whittle R; Sultan AA; Muller S; Blagojevic-Bucknall M; Helliwell T; Hider S; Roddy E; Mallen C
    BMC Med; 2018 Jan; 16(1):4. PubMed ID: 29316928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Diabetes Mellitus among Patients Diagnosed with Giant Cell Arteritis or Granulomatosis with Polyangiitis: Comparison with the General Population.
    Faurschou M; Ahlström MG; Lindhardsen J; Obel N; Baslund B
    J Rheumatol; 2017 Jan; 44(1):78-83. PubMed ID: 27744394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospitalization rates and utilization among patients with giant cell arteritis: A population-based study from 1987 to 2012.
    Michet CJ; Achenbach SJ; Crowson CS; Matteson EL
    Semin Arthritis Rheum; 2015 Aug; 45(1):70-4. PubMed ID: 25824865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study.
    Mohammad AJ; Englund M; Turesson C; Tomasson G; Merkel PA
    J Rheumatol; 2017 Jan; 44(1):84-90. PubMed ID: 27803140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and Risk of Glucocorticoid-Associated Adverse Effects in Patients With Rheumatoid Arthritis.
    Wilson JC; Sarsour K; Gale S; Pethö-Schramm A; Jick SS; Meier CR
    Arthritis Care Res (Hoboken); 2019 Apr; 71(4):498-511. PubMed ID: 29856128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospitalized infections in giant cell arteritis: a population-based retrospective cohort study.
    Udayakumar PD; Chandran AK; Crowson CS; Warrington KJ; Matteson EL
    J Rheumatol; 2014 Dec; 41(12):2447-51. PubMed ID: 25320223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink.
    Li L; Neogi T; Jick S
    Rheumatology (Oxford); 2017 May; 56(5):753-762. PubMed ID: 28077689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of infections in patients with giant cell arteritis: a cohort study.
    Durand M; Thomas SL
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):581-8. PubMed ID: 22184094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections and the risk of incident giant cell arteritis: a population-based, case-control study.
    Rhee RL; Grayson PC; Merkel PA; Tomasson G
    Ann Rheum Dis; 2017 Jun; 76(6):1031-1035. PubMed ID: 27895041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis.
    Broder MS; Sarsour K; Chang E; Collinson N; Tuckwell K; Napalkov P; Klearman M
    Semin Arthritis Rheum; 2016 Oct; 46(2):246-252. PubMed ID: 27378247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis.
    Ungprasert P; Upala S; Sanguankeo A; Warrington KJ
    Mod Rheumatol; 2016; 26(3):410-4. PubMed ID: 26381748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality in Patients With Giant Cell Arteritis: A Cohort Study in UK Primary Care.
    Li L; Neogi T; Jick S
    Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1251-1256. PubMed ID: 29409137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Severe Infections and Infection-Related Mortality During the Course of Giant Cell Arteritis: A Multicenter, Prospective, Double-Cohort Study.
    Schmidt J; Smail A; Roche B; Gay P; Salle V; Pellet H; Duhaut P
    Arthritis Rheumatol; 2016 Jun; 68(6):1477-82. PubMed ID: 26815885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in England.
    Wu J; Keeley A; Mallen C; Morgan AW; Pujades-Rodriguez M
    CMAJ; 2019 Jun; 191(25):E680-E688. PubMed ID: 31235489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year Period.
    Catanoso M; Macchioni P; Boiardi L; Muratore F; Restuccia G; Cavazza A; Pipitone N; Mancuso P; Luberto F; Salvarani C
    Arthritis Care Res (Hoboken); 2017 Mar; 69(3):430-438. PubMed ID: 27214746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occupational and socio-economic risk factors for giant cell arteritis: a nationwide study based on hospitalizations in Sweden.
    Zöller B; Li X; Sundquist J; Sundquist K
    Scand J Rheumatol; 2013; 42(6):487-97. PubMed ID: 23815287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Giant cell arteritis (Horton's disease) in very elderly patients aged 80 years and older: A study of 25 cases.
    Muller G; Devilliers H; Besancenot JF; Manckoundia P
    Geriatr Gerontol Int; 2016 Jun; 16(6):679-85. PubMed ID: 26081629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.